DOCSLIB.ORG

Rage) with Advanced Glycation End Products and S100b

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

INTERACTIONS OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) WITH ADVANCED GLYCATION END PRODUCTS AND S100B A Dissertation Submitted to the Graduate Faculty of the North Dakota State University of Agriculture and Applied Science By Venkata Shravan Kumar Indurthi In Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Major Department: Pharmaceutical Sciences October 2015 Fargo, North Dakota North Dakota State University Graduate School Title INTERACTIONS OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) WITH ADVANCED GLYCATION END PRODUCTS (AGEs) AND S100B By Venkata Shravan Kumar Indurthi The Supervisory Committee certifies that this disquisition complies with North Dakota State University’s regulations and meets the accepted standards for the degree of DOCTOR OF PHILOSOPHY SUPERVISORY COMMITTEE: Dr. Stefan Vetter Chair Dr. Stephen O’Rourke Dr. Bin Guo Dr. Christopher Colbert Approved: 11/20/2015 Dr. Jagdish Singh Date Department Chair ABSTRACT RAGE is a multi-ligand pattern recognition receptor. RAGE can bind several damage associated molecular pattern proteins. RAGE- ligand interaction is pathophysiologically relevant to several major diseases including diabetes and certain cancers. RAGE inhibition has been reported to reduce morbidity in these disease states. However, to design better RAGE inhibitors it is necessary to understand the structural basis behind the RAGE-ligand interaction and currently this is not well understood. This thesis focuses on understanding the interaction of RAGE with two of its ligands; AGEs and S100B. AGEs are highly heterogeneous and are formed as a result of non-enzymatic glycation. A panel of AGEs were characterized in terms of their side chain modifications, thermal stability, secondary structure, aggregation and surface charge. These glycation induced changes were then correlated to RAGE binding. Building on these results the role of AGE-RAGE interaction in pancreatic cancer cell proliferation and migration was determined. Ribose modified BSA induced ROS formation, which then triggered NF-κB upregulation via RAGE induced ROS signaling. Ribose BSA increased pancreatic cell proliferation and migration. Anti-RAGE antibodies and RAGE inhibitors prevented AGE induced cellular effects. The role of ribose modified BSA was also determined in macrophage activation and pro-inflammatory cytokine release. Rapid internalization was observed of the ribose-BSA and confocal imaging revealed the internalization of the AGE compound into the lysosomes which lead to the ROS production, NF- κB activation and pro-inflammatory cytokine release in a RAGE independent signaling mechanism. Finally, the role of tryptophan residues of the V domain in domain stability and S100B binding was determined. We have generated single, double and triple tryptophan mutants of the iii V domain by site directed mutagenesis. The effect of Trp residues in the domain stability could not elucidated as no change was observed in the secondary structure of the mutants when compared to the wild type suggesting the plasticity of the V-domain. The fluorescence emission and life time properties of each Trp residue was determined. Our binding assays of the Trp Ala mutants indicate tighter binding of the S100B to the mutants. The S100-RAGE peptide structures suggest multi modal interaction of S100B-RAGE interaction. iv ACKNOWLEDGEMENTS I am bereft of all words to describe the contribution of my advisor, mentor and guru Dr. Stefan Vetter. I joined the Ph.D. program at 21, I needed a guru to be the guiding light in my scientific endeavors and I am grateful to Dr. Vetter for accepting me into his lab and being the guiding light. The role he has played in my growth as a scientist is indescribable. He will always be an inspiration. I consider myself extremely fortunate to have been advised by Dr. Vetter and I am proud to be his first student. His contribution extends way beyond honing my scientific skills and has been instrumental in the overall growth of me as an individual. In the same breath, I would also like to express my deepest gratitude to Dr. Estelle Leclerc for all her contributions. To be successful it is very important to have a strong family. I am extremely fortunate to have a very supporting family. I would like to acknowledge my family; my parents, my grandparents, my sister and my brother-in-law for the unconditional support. My cousin Abhishek has been my pillar of strength during my graduate studies and would like to thank him for all his support. The last year of my graduate studies have been the toughest and the most frustrating. I cannot thank my lab mate Priyanka enough for bearing with me through this phase and making sure that I had a smile on my face every single day. My special thanks to Jean; the nicest person I have ever met and Clyde. Thank you for making me feel a part of your family and making sure I did not miss home. I have made some fabulous friendships during my graduate studies in the college of health professions, these are the people who believed in me and always motivated me to take that extra step. I would like to express my sincere gratitude to Dana, Sara, Lori and Kelly for all their support and making me feel at home here at North Dakota State University. They have an v immense contribution in making me a better person. I would like to acknowledge my friends Rhishi, Mayura, Anil, Prajakta and Gaurav for taking care of me and being there for me whenever I needed. I would like to express my heartfelt gratitude to my advisory committee, Prof. Guo, Prof. O’Rourke, and Prof. Colbert for your valuable suggestions and expert advice. Their input was instrumental in shaping me as a scientist and honing my critical reasoning skills. Finally, I would like to express my sincere gratitude to ND-EPSCoR and the graduate school for the doctoral dissertation assistantship, I am grateful to the financial support provided to me through this assistantship. vi DEDICATION Dedicated to my parents Krishnaveni and Ramesh Kumar Indurthi And my sister, Swetha Mula vii TABLE OF CONTENTS ABSTRACT ................................................................................................................................... iii ACKNOWLEDGEMENTS ............................................................................................................ v DEDICATION .............................................................................................................................. vii LIST OF TABLES ........................................................................................................................ xv LIST OF FIGURES .................................................................................................................... xvii LIST OF ABBREVIATIONS ..................................................................................................... xxii CHAPTER 1: INTRODUCTION ................................................................................................... 1 Receptor for advanced glycation end products ........................................................................... 1 RAGE-mediated NF- κB signaling ............................................................................................. 3 RAGE expression and physiological function ............................................................................ 5 RAGE and disease ....................................................................................................................... 6 CHAPTER 2: GLYCATION, ADVANCED GLYCATION END PRODUCTS (AGES) AND THEIR INTERACTION WITH RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) .......................................................................................................... 10 Introduction ............................................................................................................................... 10 Non-Enzymatic glycation and AGE compound formation ................................................... 10 AGE compounds and disease ................................................................................................ 12 AGE-specific cell surface receptors ...................................................................................... 14 Serum albumin, drug binding and glycation ......................................................................... 15 Problems associated with AGE compound research ............................................................. 17 Materials and Methods .............................................................................................................. 18 Preparation of glycated serum albumin ................................................................................. 19 UV/Vis and fluorescence spectroscopy ................................................................................. 21 Amino acid analysis .............................................................................................................. 22 Lysine side chain modification .............................................................................................. 22 viii Arginine side chain modification .......................................................................................... 22 Fructosamine content estimation ........................................................................................... 23 Carboxymethyl lysine estimation .........................................................................................
Recommended publications
  • Download on 20

    Download on 20

    bioRxiv preprint doi: https://doi.org/10.1101/850776; this version posted January 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Intramembrane protease RHBDL4 cleaves oligosaccharyltransferase subunits to target them for ER-associated degradation Julia D. Knopf1, Nina Landscheidt1, Cassandra L. Pegg2, Benjamin L. Schulz2, Nathalie Kühnle1, Chao-Wei Chao1, Simon Huck1 and Marius K. Lemberg1, # 1Centre for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany. 2School of Chemistry and Molecular Biosciences, ARC Training Centre for Biopharmaceutical Innovation, The University of Queensland, St Lucia QLD 4072, Australia. #Corresponding author: [email protected] Running title: RHBDL4 triggers ERAD of OST subunits Key words: Rhomboid serine protease, Rhbdd1, ubiquitin-dependent proteolysis, post- translational protein abundance control, N-linked glycosylation. Abbreviations ERAD, ER-associated degradation; OST, oligosacharyltransferase; TM, transmembrane; UIM, ubiquitin-interacting motif. Abstract The Endoplasmic Reticulum (ER)-resident intramembrane rhomboid protease RHBDL4 generates metastable protein fragments and together with the ER-associated degradation (ERAD) machinery provides a clearance mechanism for aberrant and surplus proteins. However, the endogenous substrate spectrum and with that the role of RHBDL4 in physiological ERAD is mainly unknown. Here, we use a substrate trapping approach in combination with quantitative proteomics to identify physiological RHBDL4 substrates. This revealed oligosacharyltransferase (OST) complex subunits such as the catalytic active subunit STT3A as substrates for the RHBDL4-dependent ERAD pathway. RHBDL4-catalyzed cleavage inactivates OST subunits by triggering dislocation into the cytoplasm and subsequent proteasomal degradation.
  • Polymorphisms with Late-Onset Alzheimer Disease in Han Chinese

    Polymorphisms with Late-Onset Alzheimer Disease in Han Chinese

    172 Original Article on Translational Neurodegeneration Page 1 of 8 Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese Zuo-Teng Wang1#, Xiao-Ling Zhong2#, Meng-Shan Tan1, Hui-Fu Wang1, Chen-Chen Tan1, Wei Zhang1, Zhan-Jie Zheng3, Ling-Li Kong3, Lan Tan1, Li Sun2 1Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao 266071, China; 2Department of Neurology, Qingdao Central Hospital, Qingdao University, Qingdao 266042, China; 3Department of Geriatric, Qingdao Mental Health Center, Qingdao 266034, China Contributions: (I) Conception and design: All authors; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (VI) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors should be regarded as co-first authors. Correspondence to: Dr. Lan Tan, MD, PhD. Department of Neurology, Qingdao Municipal Hospital, Qingdao University, No. 5 Donghai Middle Road, Qingdao 266071, China. Email: [email protected]; Dr. Li Sun, MD, PhD. Department of Neurology, Qingdao Central Hospital, Qingdao University, Qingdao 266042, China. Email: [email protected]. Background: Lectin-like oxidized low density lipoprotein receptor 1 (OLR1) locates within the area of chromosome 12p, which has been identified as the AD-susceptible region, and plays a role in lipid metabolism. Therefore, it has been suggested to be a good candidate gene for Alzheimer’s disease (AD). Several SNPs within OLR1 have been reported to have association with AD among Caucasians. Methods: We selected and genotyped three SNPs (rs1050283, rs1050286, rs17808009) in OLR1 to investigate its possible relationship with the onset of late-onset Alzheimer disease(LOAD) in 984 LOAD cases and 1,354 healthy controls among northern Han Chinese.
  • Genome Wide Analysis of TLR1/2- and TLR4-Activated SZ95 Sebocytes

    Genome Wide Analysis of TLR1/2- and TLR4-Activated SZ95 Sebocytes

    RESEARCH ARTICLE Genome wide analysis of TLR1/2- and TLR4- activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands DaÂniel ToÈ rőcsik1,2*, DoÂra KovaÂcs1, SzilaÂrd PoÂliska3, Zita Szentkereszty-KovaÂcs1, a1111111111 Marianna LovaÂszi1, Katalin Hegyi1, Andrea Szegedi1,4, Christos C. Zouboulis5, a1111111111 Mona Ståhle2 a1111111111 a1111111111 1 Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 2 Unit of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, a1111111111 Stockholm, Sweden, 3 Department of Biochemistry and Molecular Biology, Genomic Medicine and Bioinformatics Core Facility, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 4 Division of Dermatological Allergology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, 5 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodore Fontane, Dessau, Germany OPEN ACCESS * [email protected] Citation: ToÈrőcsik D, KovaÂcs D, PoÂliska S, Szentkereszty-KovaÂcs Z, LovaÂszi M, Hegyi K, et al. (2018) Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex Abstract immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands. Toll-like receptors (TLR) 2 and 4 are active in sebaceous glands and play a central role in PLoS ONE 13(6): e0198323. https://doi.org/ the development of acne. Still, there is only limited knowledge on their effect on sebocytes. 10.1371/journal.pone.0198323 In this work we performed global gene expression profile analysis with functional clustering Editor: Mauro Picardo, San Gallicano Dermatologic of the differentially regulated genes of TLR1/2 (PAM3CSK4)- and TLR4 (lipopolysaccharide Institute, ITALY [LPS])-activated SZ95 sebocytes.
  • Basic Science * Drug X Is Used for Ongoing IP/Patent Assessment Heart: First Published As 10.1136/Heartjnl-2021-BCS.199 on 4 June 2021

    Basic Science * Drug X Is Used for Ongoing IP/Patent Assessment Heart: First Published As 10.1136/Heartjnl-2021-BCS.199 on 4 June 2021

    Abstracts Basic science * Drug X is used for ongoing IP/patent assessment Heart: first published as 10.1136/heartjnl-2021-BCS.199 on 4 June 2021. Downloaded from Conflict of Interest No BS1 REPROGRAMMING HUMAN MACROPHAGES WITH DRUG X: POTENTIAL MECHANISMS FOR STABILISATION OF ATHEROSCLEROTIC PLAQUES BS2 MECHANOSENSOR PIEZO1 IN SKELETAL MUSCLE PERICYTES 1Klaudia Kocsy, 1Endre Kiss-Toth, 2Jessica Redgrave, 2Arshad Majid, 3Sheila Francis. 1Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, 1Yilizila Abudushalamu, 1Hema Viswambharan, 2Romana Mughal, 1Richard Cubbon, Sheffield, UK; 2Department of Neuroscience, The University of Sheffield, Sheffield, UK; 3The 1Mark Kearney, 1David Beech, 1Piruthivi Sukumar. 1Discovery and Translational Science University of Sheffield, Sheffield, UK Department Leeds Institute of Cardiovascular and Metabolic Medic, Leeds, UK; 2Department of Optometry and Vision Sciences School of Applied Sciences University of Huddersfield 10.1136/heartjnl-2021-BCS.199 10.1136/heartjnl-2021-BCS.200 Introduction Ischemic stroke is commonly caused by large artery atherosclerosis. Patients with a high atherosclerotic bur- Introduction Pericytes (PC) are mural cells which are present den (stenosis) and inflamed or ulcerated plaque are at in blood microvessels. They play an important part in the for- increased risk of early recurrent ischaemic events. Treatment mation and stabilization of new blood vessels. They are essen- with anti-inflammatory agents may therefore reduce stroke tial for vascular development and cardiovascular homeostasis. incidence and recurrence in patients with this condition, but They wrap around the endothelial cells (EC) and endothelial- in vitro human studies of the possible mechanisms are lacking. pericyte communication is both via physical contact and para- 1 We hypothesised that an anti-inflammatory compound crine signalling.
  • The Porcine Major Histocompatibility Complex and Related Paralogous Regions: a Review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman

    The Porcine Major Histocompatibility Complex and Related Paralogous Regions: a Review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman

    The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman To cite this version: Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman. The porcine Major Histocom- patibility Complex and related paralogous regions: a review. Genetics Selection Evolution, BioMed Central, 2000, 32 (2), pp.109-128. 10.1051/gse:2000101. hal-00894302 HAL Id: hal-00894302 https://hal.archives-ouvertes.fr/hal-00894302 Submitted on 1 Jan 2000 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Genet. Sel. Evol. 32 (2000) 109–128 109 c INRA, EDP Sciences Review The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick CHARDON, Christine RENARD, Claire ROGEL GAILLARD, Marcel VAIMAN Laboratoire de radiobiologie et d’etude du genome, Departement de genetique animale, Institut national de la recherche agronomique, Commissariat al’energie atomique, 78352, Jouy-en-Josas Cedex, France (Received 18 November 1999; accepted 17 January 2000) Abstract – The physical alignment of the entire region of the pig major histocompat- ibility complex (MHC) has been almost completed. In swine, the MHC is called the SLA (swine leukocyte antigen) and most of its class I region has been sequenced.
  • (Rage) in Progression of Pancreatic Cancer

    (Rage) in Progression of Pancreatic Cancer

    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2017 INVOLVEMENT OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IN PROGRESSION OF PANCREATIC CANCER Nancy Azizian MS Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Azizian, Nancy MS, "INVOLVEMENT OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IN PROGRESSION OF PANCREATIC CANCER" (2017). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 748. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/748 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. INVOLVEMENT OF THE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IN PROGRESSION OF PANCREATIC CANCER by Nancy
  • Glycan Engineering for Cell and Developmental Biology

    Glycan Engineering for Cell and Developmental Biology

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE HHS Public Access provided by Caltech Authors - Main Author manuscript Author ManuscriptAuthor Manuscript Author Cell Chem Manuscript Author Biol. Author Manuscript Author manuscript; available in PMC 2016 May 05. Published in final edited form as: Cell Chem Biol. 2016 January 21; 23(1): 108–121. doi:10.1016/j.chembiol.2015.12.007. Glycan Engineering for Cell and Developmental Biology Matthew E. Griffin1 and Linda C. Hsieh-Wilson1,* 1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, USA Abstract Cell-surface glycans are a diverse class of macromolecules that participate in many key biological processes, including cell-cell communication, development, and disease progression. Thus, the ability to modulate the structures of glycans on cell surfaces provides a powerful means not only to understand fundamental processes but also to direct activity and elicit desired cellular responses. Here, we describe methods to sculpt glycans on cell surfaces and highlight recent successes in which artificially engineered glycans have been employed to control biological outcomes such as the immune response and stem cell fate. Introduction Cell-surface glycans participate in many important processes throughout the lifespan of an organism, ranging from cell migration and tissue patterning to the immune response, disease progression, and cell death (Fuster and Esko, 2005; Häcker et al., 2005; Lichtenstein and Rabinovich, 2013; van Kooyk and Rabinovich, 2008). At a molecular level, glycans are often the first points of contact between cells, and they function by facilitating a variety of interactions both in cis (on the same cell) and in trans (on different cells).
  • Evaluating the Effect of TLR4-Overexpressing on The

    Evaluating the Effect of TLR4-Overexpressing on The

    Guo et al. J of Biol Res-Thessaloniki (2020) 27:13 https://doi.org/10.1186/s40709-020-00124-3 Journal of Biological Research-Thessaloniki RESEARCH Open Access Evaluating the efect of TLR4-overexpressing on the transcriptome profle in ovine peripheral blood mononuclear cells Xiaofei Guo1†, Jinlong Zhang1,2†, Yao Li2, Jing Yang1, Yihai Li1, Chunxiao Dong1, Guoshi Liu2, Zhengxing Lian2 and Xiaosheng Zhang1* Abstract Background: Toll-like receptor 4 (TLR4) plays an important role in the elimination of Gram-negative bacteria infec- tions and the initiation of antiinfammatory response. Using the technology of pronuclear microinjection, genetically modifed (GM) sheep with TLR4 overexpression were generated. Previous studies have shown that these GM sheep exhibited a higher infammatory response to Gram-negative bacteria infection than wild type (WT) sheep. In order to evaluate the gene expression of GM sheep and study the co-expressed and downstream genes for TLR4, peripheral blood mononuclear cells (PBMC) from TLR4-overexpressing (Tg) and wild type (WT) sheep were selected to discover the transcriptomic diferences using RNA-Seq. Result: An average of 18,754 and 19,530 known genes were identifed in the Tg and WT libraries, respectively. A total of 338 known genes and 85 novel transcripts were found to be diferentially expressed in the two libraries (p < 0.01). A diferentially expressed genes (DEGs) enrichment analysis showed that the GO terms of infammatory response, cell recognition, etc. were signifcantly (FDR < 0.05) enriched. Furthermore, the above DEGs were signifcantly (FDR < 0.05) enriched in the sole KEGG pathway of the Phagosome. Real-time PCR showed the OLR1, TLR4 and CD14 genes to be diferentially expressed in the two groups, which validated the DEGs data.
  • Modulation of Cell-Mediated Immunity by HIV-1 Infection of Macrophages

    Modulation of Cell-Mediated Immunity by HIV-1 Infection of Macrophages

    Modulation of cell-mediated immunity by HIV-1 infection of macrophages Lucy Caitríona Kiernan Bell Division of Infection and Immunity University College London PhD Supervisor: Dr Mahdad Noursadeghi A thesis submitted for the degree of Doctor of Philosophy University College London August 2014 Declaration I, Lucy Caitríona Kiernan Bell, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Cell-mediated immunity (CMI) is central to the host response to intracellular pathogens such as Mycobacterium tuberculosis (Mtb). The function of CMI can be modulated by human immunodeficiency virus (HIV)-1 via its pleiotropic effects on the immune response, including modulation of macrophages, which are parasitized by both HIV-1 and Mtb. HIV-1 infection is associated with increased risk of tuberculosis (TB), and so in this thesis I sought to explore the host/pathogen interactions through which HIV-1 dysregulates CMI, and thus changes the natural history of TB. Using an in vitro model of human monocyte-derived macrophages (MDMs), I characterise a phenotype wherein HIV-1 specifically attenuates production of the immunoregulatory cytokine interleukin (IL)-10 in response to Mtb and other innate immune stimuli. I show that this phenotype requires HIV-1 integration and gene expression, and may result from a function of the HIV-1 accessory proteins. I identify that the phosphoinositide 3-kinase (PI3K) pathway specifically regulates IL-10 production in human MDMs, and thus may be a target for HIV-1 to mediate IL-10 attenuation.
  • Scavenger Receptor CD36 Is Essential for the Cerebrovascular Oxidative Stress and Neurovascular Dysfunction Induced by Amyloid-Β

    Scavenger Receptor CD36 Is Essential for the Cerebrovascular Oxidative Stress and Neurovascular Dysfunction Induced by Amyloid-Β

    Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β Laibaik Parka, Gang Wanga, Ping Zhoua, Joan Zhoua, Rose Pitstickb, Mary Lou Previtic, Linda Younkind, Steven G. Younkind, William E. Van Nostrandc, Sunghee Choe, Josef Anrathera, George A. Carlsonb, and Costantino Iadecolaa,1 aDivision of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065; bMcLaughlin Research Institute, Great Falls, MT 56405; cDepartment of Neurosurgery, Stony Brook University, Stony Brook, NY 11794; dMayo Clinic Jacksonville, Jacksonville, FL 32224; and eDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, Burke Rehabilitation Center, White Plains, NY 10605 Edited by Thomas C. Südhof, Stanford University School of Medicine, Palo Alto, CA, and approved February 8, 2011 (received for review October 14, 2010) Increasing evidence indicates that cerebrovascular dysfunction anisms ensure that the brain receives a sufficient amount of plays a pathogenic role in Alzheimer’s dementia (AD). Amyloid-β blood flow at all times (9). For example, functional hyperemia (Aβ), a peptide central to the pathogenesis of AD, has profound matches the delivery of blood flow with the metabolic demands vascular effects mediated, for the most part, by reactive oxygen imposed by neural activity, whereas vasoactive agents released species produced by the enzyme NADPH oxidase. The mechanisms from endothelial cells regulate microvascular flow (9). Aβ1–40, β linking A to NADPH oxidase-dependent vascular oxidative stress but not Aβ1–42, disrupts these vital homeostatic mechanisms, have not been identified, however. We report that the scavenger leading to neurovascular dysfunction and increasing the suscep- receptor CD36, a membrane glycoprotein that binds Aβ, is essen- tibility of the brain to injury (3).
  • Critical Role of Oxidized LDL Receptor-1 in Intravascular

    Critical Role of Oxidized LDL Receptor-1 in Intravascular

    www.nature.com/scientificreports OPEN Critical role of oxidized LDL receptor‑1 in intravascular thrombosis in a severe infuenza mouse model Marumi Ohno1, Akemi Kakino2, Toshiki Sekiya1, Naoki Nomura1, Masashi Shingai1, Tatsuya Sawamura2 & Hiroshi Kida1* Although coagulation abnormalities, including microvascular thrombosis, are thought to contribute to tissue injury and single‑ or multiple‑organ dysfunction in severe infuenza, the detailed mechanisms have yet been clarifed. This study evaluated infuenza‑associated abnormal blood coagulation utilizing a severe infuenza mouse model. After infecting C57BL/6 male mice with intranasal applications of 500 plaque‑forming units of infuenza virus A/Puerto Rico/8/34 (H1N1; PR8), an elevated serum level of prothrombin fragment 1 + 2, an indicator for activated thrombin generation, was observed. Also, an increased gene expression of oxidized low‑density lipoprotein (LDL) receptor‑1 (Olr1), a key molecule in endothelial dysfunction in the progression of atherosclerosis, was detected in the aorta of infected mice. Body weight decrease, serum levels of cytokines and chemokines, viral load, and infammation in the lungs of infected animals were similar between wild‑type and Olr1 knockout (KO) mice. In contrast, the elevation of prothrombin fragment 1 + 2 levels in the sera and intravascular thrombosis in the lungs by PR8 virus infection were not induced in KO mice. Collectively, the results indicated that OLR1 is a critical host factor in intravascular thrombosis as a pathogeny of severe infuenza. Thus, OLR1 is a promising novel therapeutic target for thrombosis during severe infuenza. Infuenza is a respiratory disease and remains a major health concern, causing approximately half a million deaths per year globally1.
  • RAGE Regulates the Metabolic and Inflammatory Response to High-Fat

    RAGE Regulates the Metabolic and Inflammatory Response to High-Fat

    1948 Diabetes Volume 63, June 2014 Fei Song,1 Carmen Hurtado del Pozo,1 Rosa Rosario,1 Yu Shan Zou,1 Radha Ananthakrishnan,1 Xiaoyuan Xu,2 Payal R. Patel,3 Vivian M. Benoit,3 Shi Fang Yan,1 Huilin Li,4 Richard A. Friedman,5 Jason K. Kim,3 Ravichandran Ramasamy,1 Anthony W. Ferrante Jr.,2 and Ann Marie Schmidt1 RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice Diabetes 2014;63:1948–1965 | DOI: 10.2337/db13-1636 In mammals, changes in the metabolic state, including The constellation of obesity, insulin resistance, and di- obesity, fasting, cold challenge, and high-fat diets abetes results from the integration of metabolic and (HFDs), activate complex immune responses. In many inflammatory signals. When imbalances in caloric intake strains of rodents, HFDs induce a rapid systemic and energy expenditure contribute to obesity, disordered inflammatory response and lead to obesity. Little is cross-talk among adipocytes, liver, brain, and skeletal known about the molecular signals required for HFD- muscle emerges, thereby eliciting cues that result in induced phenotypes. We studied the function of the tissue recruitment of inflammatory cells. A consequence of receptor for advanced glycation end products (RAGE) inflammatory cell recruitment to key metabolic organs, in the development of phenotypes associated with particularly macrophage populations to visceral adipose high-fat feeding in mice. RAGE is highly expressed on tissue, is the derangement of the insulin signaling pathway, immune cells, including macrophages. We found that leading to impaired glucose and lipid homeostasis (1–5). high-fat feeding induced expression of RAGE ligand In this context, we hypothesized that receptor for HMGB1 and carboxymethyllysine-advanced glycation advanced glycation end products (RAGE) might contrib- end product epitopes in liver and adipose tissue.